Biotechnology company specializing on vertical integrated global cannabis and hemp cannabinoids to with an aim of improving the cannabinoid industry Canbud Distribution Corp. (CSE: CBDX) announced having a license from Health Canada giving the company permission to deal with psilocybin.
Canbud which is a wholly owned subsidiary of leading cannabis company Molecular Science Corp. (MSC) says it received its dealer’s license from Health Canada on July 30, 2021. This approval means the Canbud has joined the small list of companies approved to work with psilocybin by Health Canada.
The company terms this development as a remarkable milestone since going forward it will now be able to possess, sale, test and transport controlled psychedelics substances like psilocybin, ketamine and DMT among others.
